This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Moody's Disagrees on MetLife 'Shadow Insurance' Risk

NEW YORK ( TheStreet) -- Metlife (MET - Get Report) says ending a practice of so-called "shadow insurance" could cut at the insurer's credit rating and lead to higher costs for consumers. Moody's, a top ratings agency, appears to disagree.

The apparent difference of opinion centers on an alleged $48 billion of claims life insurers such as Metlife, Lincoln National Life Insurance, Genworth (GNW) and Prudential (PRU - Get Report) move from their balance sheets to captive reinsurance subsidiaries and the perceived costs firms would incur to make those claims more transparent to regulators, investors and policyholders.

According to a recent report from the New York State Department of Financial Services and New York State Governor Andrew Cuomo, insurers have exploited loopholes to throw some life and health insurance products into off-balance-sheet entities, minimizing reported liabilities and the capital a firm would need to service them.

Metlife says moving policies back on its balance sheet could cause ratings downgrades, increase its cost of its capital and raise prices for customers. Moody's, however, says a better disclosure and capitalization of claims may actually be "credit positive" for industry-wide ratings.

Life insurers use reinsurance subsidiaries to finance reserve requirements for term and universal life policies with secondary guarantees, MetLife says. Any alternative to put those policies back on the balance sheet would come with big costs, the insurer states.

"Using equity could reduce returns to levels below those required by investors and issuing debt could negatively impact credit ratings," MetLife spokesperson John Calagna said in an e-mailed statement June 12. "Access to reinsurance subsidiaries significantly reduces costs to policyholders and in some cases is necessary to enable insurers to continue to offer certain coverage."

Moody's, however, only sees benefits for the industry.

"We believe that a greater focus on captives by regulators is credit positive for the industry," Scott Robinson, a Moody's Senior Vice President, writes in a Monday report. "Our analysis of life insurance companies' creditworthiness on an enterprise basis has determined that many companies' captives are capitalized at lower levels than standard operating companies."

According to a June 12 report from Cuomo and DFS superintendent Benjamin Lawsky, New York-based insurance companies -- the only ones that would fall under its jurisdiction -- failed to disclose the guarantees associated with nearly 80% of $48 billion in shadow insurance in their financial statements using captives.

Life insurers use those off-balance sheet vehicles to manage the regulatory burden of life and health insurance products and the reserve requirements of variable annuity guarantees.

"Both practices undermine the conservatism regulators have embedded in the reserving and capital regimes," Robinson, the Moody's SVP added in the Monday note.
1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
MET $48.39 -0.47%
PRU $78.08 -0.26%
GEN $5.92 1.89%
AAPL $112.12 2.39%
FB $93.24 0.83%


Chart of I:DJI
DOW 17,084.49 +33.74 0.20%
S&P 500 2,013.43 +15.91 0.80%
NASDAQ 4,830.47 +19.6820 0.41%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs